SQZ Biotechnologies Co Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SQZ Biotechnologies Co quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2023.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $983K, a 58.6% decline year-over-year.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $4.6M, a 48.5% decline year-over-year.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2022 was $8.4M, a 1.2% decline from 2021.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2021 was $8.51M, a 136% increase from 2020.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2020 was $3.6M, a 70.9% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $4.6M $983K -$1.39M -58.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6M $1.15M -$1.16M -50.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $7.15M $695K -$1.25M -64.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $8.4M $1.77M -$541K -23.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-22
Q3 2022 $8.94M $2.38M -$405K -14.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $9.35M $2.31M +$478K +26.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $8.87M $1.95M +$366K +23.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $8.51M $2.31M +$960K +70.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $7.55M $2.78M +$1.99M +249% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.56M $1.83M +$1.08M +143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $4.49M $1.58M +$883K +127% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.6M $1.35M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 $796K +$305K +62.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $754K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $698K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $491K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.